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Esteemed editor, 
Studies evaluating non-traumatic splenectomy in patients with myeloid and lymphoid malignancies 
reported particularly higher morbidity and mortality rates, ranging between 24 – 52 % and 2 – 18% 
respectively.
1-4
 Infectious complications including sepsis have been reported to be significantly more 
common in patients with malignant indications for splenectomy.
5
 The goal of this analysis was to evaluate 
the risk of post-operative septic events in patients undergoing splenectomy for lymphoid and myeloid 
malignancies as compared to patients with non-malignant, benign indications.   
Our study was a retrospective cohort study of the prospective validated American College of Surgeons 
National Surgical Quality Improvement Program (ACS-NSQIP) database from 2008 to 2016. Cases with 
the Current Procedural Terminology® (CPT) codes 38100 and 38120 were included. These CPT codes 
included all the cases of total splenectomy, laparoscopic and open, that were not performed as add-on 
procedures. Cases with CPT codes 38101 (partial splenectomy) and 38102 (splenectomy as add-on 
procedure) were not included in the analysis. Only the index case was included for patients undergoing 
more than one procedure. Patients were not included more than once in the analysis.  
The patient population was subsequently stratified based on whether the postoperative diagnosis was part 
of the pre-identified group of “malignant lymphoid and myeloid neoplasms/leukemia.” This group of 
diseases included the following International Classification of Disease Ninth Edition (ICD-9) diagnoses 
(200.X – 208.X) and International Classification of Disease Tenth Edition (ICD-10) diagnoses (C81.X – 
C96.X). This group of diagnoses includes lymphosarcoma, Hodgkin’s disease, other malignant neoplasms 
of lymphoid and histiocytic tissue, multiple myeloma, immunoproliferative neoplasms, lymphoid 
leukemia, myeloid leukemia, monocytic leukemia, and other leukemic diseases).  
The primary outcome measure was the incidence of postoperative septic events, including sepsis and 
septic shock, at 30 days of the index surgery in the group with lymphoid and myeloid malignancy 
(neoplasms or leukemia as previously defined) compared with the group without lymphoid or myeloid 
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malignancy. Sepsis was defined per ACS-NSQIP based on the following criteria: (a) sepsis was 
considered present when a subject had evidence of systemic inflammatory response syndrome and either 
(i) positive blood culture (or clinical documentation of purulence or positive culture from any site for 
which there is documentation noting the site as the acute case of sepsis) or (ii) suspected preoperative 
clinical condition of infection or bowel infarction leading to the surgical procedure. Septic shock was 
defined as sepsis with documented organ and/or circulatory dysfunction. Both sepsis and septic shock 
were considered septic events. A multivariate logistic regression model for postoperative septic events at 
30 days was created with adjusted odds ratios (ORadj). Clinically relevant potential confounders in each 
separate model were considered for adjustments. Stepwise regression was performed with an entry level 
of 0.25 and a stay level of 0.15. The association was further evaluated across strata of age, sex, and 
emergency status. The interaction was assessed for the 30-day septic events outcome. All p values were 2-
sided with level of significance <0.05. Statistical analysis was done using Statistical Analysis System 
(SAS). In compliance with the guidelines of the American University of Beirut Institutional Review 
Board (IRB), ethical review was not needed for our analysis.  
A total of 7,721 patients met the inclusion criteria and were included in the analysis. The mean age of the 
patients was 54.0 years (SD 17.69 years). 52.5% of patients were female. 4,081 (52.9%) of the procedures 
were done laparoscopically. Baseline characteristics are reported in Supplementary Table 1. There was no 
statistically significant difference in postoperative septic events between the patients who underwent 
splenectomy for lymphoid malignancy versus those who underwent splenectomy for other indications 
without adjusting for other factors. Unadjusted risk for 30-day postoperative septic events was not 
statistically significantly different (ORunadjusted = 1.16 with a 95% CI of 0.85 – 1.57) between patients with 
lymphoid or myeloid malignancy and patients with benign indications for splenectomy. Table 1 shows the 
non-stratified and stratified results on 30-day postoperative septic events across the different groups. For 
patients with lymphoid or myeloid malignancy undergoing splenectomy, the adjusted OR for 
postoperative septic events was 1.20 (95% confidence interval of 0.87 – 1.66) as compared to patients 
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with other postoperative diagnoses. Based on the adjusted OR, patients with myeloid and lymphoid 
neoplasms were not at a higher risk of postoperative septic events. When the subgroups were stratified by 
age, sex, and emergency status, females undergoing splenectomy for a malignant indication were at a 
statistically significantly increased risk of postoperative septic events with ORadjusted = 1.83 (95% 
confidence interval of 1.12 – 2.99) when compared with females undergoing splenectomy for other 
indications.  
In our analysis, the preoperative risk factors found to be associated with postoperative septic events 
included older age, age 65 years or older, male sex, functional dependence, and inpatient hospitalization 
status. Having a higher American Society of Anesthesiologists class was associated with higher risk for 
postoperative septic events. The use of general anesthesia did not affect the risk of postoperative septic 
events. Emergency cases were associated with two-fold increased risk of postoperative septic events. 
Perioperative transfusion, longer operative time, and open approach (versus laparoscopic) were associated 
with increased risk of postoperative sepsis. These results are similar to the findings of the study by 
Bagrodia et al evaluating morbidity and mortality following elective splenectomy.
5
 Patients with chronic 
heart failure and hypertension were at a higher risk of postoperative septic events. Pulmonary 
comorbidities including ventilator dependence and severe chronic obstructive pulmonary disease were 
associated with increased risk of postoperative septic events. These findings are similar to the findings by 
Neuwirth et al.
2
 Smoking was not found to be associated with increased risk of postoperative septic 
events – a result consistent with findings in the literature.1 Higher INR (greater than 1.4), lower 
hematocrit, and leukocytosis were associated with an increased risk of postoperative septic events. 
Diabetes mellitus, weight loss, and lower serum albumin were associated with higher risk of postoperative 
septic events; these results were consistent with findings in the literature.
1,5
 
Previous studies have established that elective splenectomy for malignant conditions has a higher 
complication rate than splenectomy for benign conditions.
3,5,6
 Our study validates the risk factors 
associated with infectious complications from previous studies.
1,5
 In our analysis, the adjusted risk for 
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postoperative septic events remains similar between the group undergoing splenectomy for malignant 
indications and the group undergoing splenectomy for benign indications. Our study did not find a 
differential effect of age on risk of postoperative septic events upon stratification. However, female 
patients undergoing splenectomy for lymphoid and myeloid neoplasms were at ~ 1.8-fold increased risk 
of postoperative septic events when compared to female patients undergoing splenectomy for benign 
indications. This differential effect had not been identified in previous studies.  
The strengths of our study include the large, multicenter ACS-NSQIP database from which the data was 
extracted. The sample is thought to be representative of the pool of all the patients undergoing surgery in 
the United States, but there could exist aspects that the database does not accurately reflect. Another 
limitation is the 30-day postoperative follow-up. This relatively short period of follow-up captures most 
post-operative complications, especially those relevant to the outcomes of our study but may miss long-
term outcomes. Potential missing confounders include preoperative vaccination status and antibiotic 
treatment in the postoperative period. 
Our analysis suggests that, while pursuing measures to prevent infectious complications of splenectomy 
in patients undergoing the procedure for benign or malignant indications, special attention should be 
given to patients with the risk factors identified in this study including older patients with cardiovascular 
comorbidities, pulmonary comorbidities, renal comorbidities, malnutrition, need for perioperative 
transfusion, and coagulopathy. Among female patients, those undergoing splenectomy for malignant 
indications are at an increased risk as compared to females undergoing splenectomy for benign 
indications. The results shed light on another area of potential disparity in care and invites more 
prospective studies to evaluate this differential effect seen only in the female group. 
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Table 1. Overall and stratified effects of surgical indication (malignant versus benign) on risk of 
postoperative septic events 
 
Septic events Unadjusted Adjusted 
No Yes   
n = 7329 n = 392 
OR (95% 
CI) 
p-
value 
OR (95% 
CI) 
p-
value 
Lymphoid/myeloid neoplasms (%) 823 (11.2) 50 (12.8) 
1.16 (0.85 – 
1.57) 
0.35 
1.20 (0.87 
– 1.66) 
0.26 
Stratified analysis of patients with lymphoid/myeloid neoplasms 
Age  
        <65 years (n=5241) 410 (8.2) 27 (10.9) 
1.37 (0.91 – 
2.07) 
0.13 1.44 (0.93 
– 2.24) 
0.10 
        65+ years (n=2480) 413 (17.7) 23 (15.9) 
0.88 (0.55 – 
1.39) 
0.57 1.01 (0.62 
– 1.64) 
0.98 
   Sex  
        Male (n=3663) 457 (13.3) 28 (12.0) 
0.89 (0.59 – 
1.33) 
0.57 1.02 (0.66 
– 1.58) 
0.93 
        Female (n=4048) 366 (9.4) 22 (13.8) 
1.55 (0.97 – 
2.46) 
0.06 1.83 (1.12 
– 2.99) 
0.02 
   Emergency   
        No (n=6549) 784 (12.5) 45 (17.1) 
1.45 (1.04 – 
2.01) 
0.03 1.28 (0.90 
– 1.81) 
0.17 
        Yes (n=1172) 39 (3.7) 5 (3.4) 
1.03 (0.40 – 
2.68) 
0.81 1.04 (0.38 
– 2.79) 
0.94 
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